Bio-Rad Laboratories Class A
BIO
241 hedge funds and large institutions have $2.62B invested in Bio-Rad Laboratories Class A in 2015 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 86 increasing their positions, 85 reducing their positions, and 27 closing their positions.
240% more call options, than puts
Call options by funds: $1.19M | Put options by funds: $351K
1% more repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 85
0.5% less ownership
Funds ownership: 78.58% → 78.08% (-0.5%)
9% less capital inflows, than outflows
Capital inflows: $168M | Capital outflows: $185M
1% less funds holding
Funds holding: 244 → 241 (-3)
19% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 27
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Credit Suisse
Zurich,
Switzerland
|
+$17.8M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
+$15.2M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$13.2M |
| 4 |
HSBC Holdings
London,
United Kingdom
|
+$10.4M |
| 5 |
Bank of Nova Scotia
Toronto,
Ontario, Canada
|
+$10.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
-$38.6M |
| 2 |
Millennium Management
New York
|
-$28.7M |
| 3 |
Royce & Associates
New York
|
-$15M |
| 4 |
UBS AM
Chicago,
Illinois
|
-$14.7M |
| 5 |
Oxford Asset Management
Oxford,
United Kingdom
|
-$9.24M |
BIO Hedge Fund Activity: Q4 2015 in Review
241 of the 3,823 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q4 2015, worth a combined $2.62B — up 3.2% from $2.54B a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of BIO and 22 opened new positions — a net loss of 5 holders — while 85 trimmed existing stakes and 86 added.
The largest buyer was Credit Suisse, adding an estimated $17.8M. The largest seller was BNP Paribas Financial Markets, cutting an estimated $38.6M.
- 241 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q4 2015, down from 244 in Q3 2015.
- Funds reported $2.62B of Bio-Rad Laboratories Class A stock for Q4 2015, up 3.2% quarter-over-quarter.
- 22 funds opened new Bio-Rad Laboratories Class A positions in Q4 2015 and 27 closed out, a net change of -5 holders.
- The largest Bio-Rad Laboratories Class A buyer in Q4 2015 was Credit Suisse, an estimated $17.8M added.
- The largest Bio-Rad Laboratories Class A seller in Q4 2015 was BNP Paribas Financial Markets, an estimated $38.6M sold.
Based on aggregated 13F filings for Q4 2015.